Atrial Natriuretic Peptide for the Prevention of Contrast-Induced Nephropathy. What's Old Is New But at the Right Dose and Duration of Therapy!

Journal of the American College of Cardiology

Volumn 53, Issue 12, 2009, Pages 1047-1049

  Chen, Horng H ^a  

^a MAYO CLINIC   (United States)

Author keywords

atrial natriuretic peptide; contrast induced nephropathy; coronary angiography; creatinine; eGFR

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CONTRAST MEDIUM; CREATININE; NESIRITIDE; PLACEBO; RINGER SOLUTION;

ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG MEGADOSE; EDITORIAL; HUMAN; HYPOTENSION; LOW DRUG DOSE; MEDICAL LITERATURE; PREVALENCE; PRIORITY JOURNAL;

ATRIAL NATRIURETIC FACTOR; CONTRAST MEDIA; HUMANS; KIDNEY FAILURE;

EID: 61949217550     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.12.020     Document Type: Editorial

References (20)

1. Barrett B.J., and Parfrey P.S. Prevention of nephrotoxicity induced by radiocontrast agents. N Engl J Med 331 (1994) 1449-1450
2. Tublin M.E., Murphy M.E., and Tessler F.N. Current concepts in contrast media-induced nephropathy. AJR Am J Roentgenol 171 (1998) 933-939
3. Morcos S.K., Thomsen H.S., and Webb J.A. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 9 (1999) 1602-1613
4. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275 (1996) 1489-1494
5. Weisberg L.S., Kurnik P.B., and Kurnik B.R. Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction. Kidney Int 41 (1992) 1408-1415
6. Persson P.B., Hansell P., and Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 68 (2005) 14-22
7. Kelly A.M., Dwamena B., Cronin P., Bernstein S.J., and Carlos R.C. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 148 (2008) 284-294
8. Morikawa S., Sone T., Tsuboi H., et al. Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide. J Am Coll Cardiol 53 (2009) 1040-1046
9. Chen H.H., and Burnett Jr. J.C. The natriuretic peptides in heart failure: diagnostic and therapeutic potentials. Proc Assoc Am Physicians 111 (1999) 406-416
10. Margulies K.B., and Burnett Jr. J.C. Atrial natriuretic factor modulates whole kidney tubuloglomerular feedback. Am J Physiol 259 (1990) R97-R101
11. Butlen D., Mistaoui M., and Morel F. Atrial natriuretic peptide receptors along the rat and rabbit nephrons: [125I] alpha-rat atrial natriuretic peptide binding in microdissected glomeruli and tubules. Pflugers Arch 408 (1987) 356-365
12. Allgren R.L., Marbury T.C., Rahman S.N., et al., Auriculin Anaritide Acute Renal Failure Study Group. Anaritide in acute tubular necrosis. N Engl J Med 336 (1997) 828-834
13. Lewis J., Salem M.M., Chertow G.M., et al., Anaritide Acute Renal Failure Study Group. Atrial natriuretic factor in oliguric acute renal failure. Am J Kidney Dis 36 (2000) 767-774
14. Sward K., Valsson F., Odencrants P., Samuelsson O., and Ricksten S.E. Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial. Crit Care Med 32 (2004) 1310-1315
15. Kurnik B.R., Allgren R.L., Genter F.C., Solomon R.J., Bates E.R., and Weisberg L.S. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 31 (1998) 674-680
16. Sackner-Bernstein J.D., Skopicki H.A., and Aaronson K.D. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111 (2005) 1487-1491
17. Wang D.J., Dowling T.C., Meadows D., et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation 110 (2004) 1620-1625
18. Chen H.H., Sundt T.M., Cook D.J., Heublein D.M., and Burnett Jr. J.C. Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study. Circulation 116 (2007) I134-I138
19. Riter H.G., Redfield M.M., Burnett J.C., and Chen H.H. Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction. J Am Coll Cardiol 47 (2006) 2334-2335
20. Mentzer Jr. R.M., Oz M.C., Sladen R.N., et al. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery: the NAPA trial. J Am Coll Cardiol 49 (2007) 716-726